Work

Safety and Activity of Flotetuzumab in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia: Results from the COG PEPN1812 Phase 1 Trial

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-158029

Authors: Adam J. Lamble, Xiaowei Liu, Charles Minard, Olga Militano, Melanie Brooke Bernhardt, Todd M. Cooper, Edward A. Kolb, Erin H. Breese, Elizabeth Fox, Sarah K Tasian, Brenda J. Weigel

Institutions: Seattle Children's Hospital, Children's Oncology Group, Baylor College of Medicine, Texas Children's Hospital, Alfred I. duPont Hospital for Children, Stanford Health Care, St. Jude Children's Research Hospital, Children's Hospital of Philadelphia, University of Minnesota

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310157901

FWCI: 1.879

Cites:

Cited by: 14

Related to: 10